Laura Bonanno

17PUBLICATIONS
105CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 28, 2026
Feasibility of Minimally Invasive Surgery After Chemo-Immunotherapy in Locally Advanced and Oligometastatic NSCLC: Technical Aspects and Surgical Outcomes.

|Dec 17, 2025
Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Fabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino

|Nov 17, 2025
Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Fabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino

|May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial.

Tina Cascone, Laura Bonanno, Florian Guisier

|Jan 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.

Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte

|Oct 17, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer.

Andrea Boscolo Bragadin, Paola Del Bianco, Elisabetta Zulato

Pageof 3

Frequent Collaborators

4 joint publications

Alessandro Dal Maso

4 joint publications

Giulia Pasello

4 joint publications

Stefano Indraccolo

3 joint publications

Sara Pilotto